CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $30.29B, higher than 95% of all stocks globally
- PositionOperating margin is 31.2%, higher than 95% of its Diagnostics & Research peers (median 8.5%)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
30.29BUSDvs all stocks (USD)
Trailing P/E
34.11xvs Diagnostics & Research peers
Revenue (TTM)
4.13BUSDvs all stocks (USD)
Profit Margin
21.91%vs Diagnostics & Research peers
Beta
1.22xvs all stocks
52-Week Change
26.88%vs all stocks
Market Capitalization
30.29BUSDvs all stocks (USD)
Enterprise Value
32.37BUSDvs all stocks (USD)
Trailing P/E
34.11xvs Diagnostics & Research peers
Forward P/E
29.24xvs Diagnostics & Research peers
PEG Ratio
1.86xPrice to Sales (TTM)
7.33xvs Diagnostics & Research peers
Price to Book (MRQ)
2.36Kxvs Diagnostics & Research peers
Enterprise to Revenue
7.83xvs Diagnostics & Research peers
Enterprise to EBITDA
25.38xvs Diagnostics & Research peers
Gross Margin
63.29%vs Diagnostics & Research peers
Profit Margin
21.91%vs Diagnostics & Research peers
Operating Margin
31.20%vs Diagnostics & Research peers
Return on Assets (TTM)
21.10%vs Diagnostics & Research peers
Return on Equity (TTM)
-3677.41%vs Diagnostics & Research peers
Revenue (TTM)
4.13BUSDvs all stocks (USD)
Revenue per Share (TTM)
203.41USDUpdated Sep 28, 2026Quarterly Revenue Growth
4.50%vs Diagnostics & Research peers
Gross Profit (TTM)
2.49BUSDvs all stocks (USD)
EBITDA (TTM)
1.32BUSDvs all stocks (USD)
Net Income (TTM)
905.61MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
15.10%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
975.17MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
693.59MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
4.03BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.64BUSDFY2025 · Dec 31, 2025Gross Profit
2.39BUSDFY2025 · Dec 31, 2025Operating Income
1.12BUSDvs all stocks (USD)
Pre-tax Income
1.05BUSDFY2025 · Dec 31, 2025Income Tax Expense
179.72MUSDFY2025 · Dec 31, 2025Net Income
869.19MUSDFY2025 · Dec 31, 2025EBIT
1.12BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.26BUSDFY2025 · Dec 31, 2025Research & Development
199.37MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
998.31MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
68.52MUSDFY2025 · Dec 31, 2025EPS (Basic)
42.17USDFY2025 · Dec 31, 2025EPS (Diluted)
42.05USDFY2025 · Dec 31, 2025Basic Shares Outstanding
20.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
20.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
869.19MUSDFY2025 · Dec 31, 2025Operating Cash Flow
990.02MUSDFY2025 · Dec 31, 2025Free Cash Flow
882.89MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
66.89MUSDFY2025 · Dec 31, 2025Income Tax Paid
180.85MUSDFY2025 · Dec 31, 2025Interest Paid
66.63MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
869.19MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
125.61MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
3.79MUSDFY2025 · Dec 31, 2025Stock-based Compensation
22.51MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-46.35MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
33.76MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.50MUSDFY2025 · Dec 31, 2025Capital Expenditures
-107.12MUSDFY2025 · Dec 31, 2025Net Acquisitions
-93.84MUSDFY2025 · Dec 31, 2025Other Investing Activity
7.09MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-193.87MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
2.00BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.97BUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-800.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-8.91MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-787.45MUSDFY2025 · Dec 31, 2025Shares Outstanding
20.04MSharesUpdated Sep 28, 2026Float Shares
19.93MSharesUpdated Sep 28, 2026Shares Short
697.79KSharesUpdated Sep 28, 2026Short Ratio
3.86daysvs all stocks
Short % of Shares Outstanding
4.00%vs all stocks
% Held by Insiders
0.44%vs all stocks
% Held by Institutions
105.33%vs all stocks
Total Cash (MRQ)
51.38MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.56USDUpdated Sep 28, 2026Total Debt (MRQ)
2.14BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
166.68xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.12xvs Diagnostics & Research peers
Book Value per Share (MRQ)
0.6400USDUpdated Sep 28, 2026Total Assets
3.71BUSDvs all stocks (USD)
Total Current Assets
1.36BUSDFY2025 · Dec 31, 2025Total Liabilities
3.74BUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.35BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.54BUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.20BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
66.89MUSDFY2025 · Dec 31, 2025Accounts Receivable
778.24MUSDFY2025 · Dec 31, 2025Inventory
387.23MUSDFY2025 · Dec 31, 2025Accounts Payable
266.63MUSDFY2025 · Dec 31, 2025Short-term Debt
63.93MUSDFY2025 · Dec 31, 2025Deferred Revenue
229.38MUSDFY2025 · Dec 31, 2025Long-term Debt
2.09BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
298.14MUSDFY2025 · Dec 31, 2025Common Stock (Book)
448.00KUSDFY2025 · Dec 31, 2025Retained Earnings
9.24BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
-23.64MUSDvs all stocks (USD)
Treasury Stock
9.84BUSDFY2025 · Dec 31, 202552-Week Low
1.02KUSDUpdated Sep 28, 202652-Week High
1.54KUSDUpdated Sep 28, 202652-Week Change
26.88%vs all stocks
Beta
1.22xvs all stocks
50-Day MA
1.39KUSDUpdated Sep 28, 2026200-Day MA
1.32KUSDUpdated Sep 28, 2026Avg 10-Day Volume
270.57KSharesUpdated Sep 28, 2026Avg 30-Day Volume
208.05KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
44.32USDUpdated Sep 28, 2026Other Income / Expense
-1.07MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 31.2%, higher than 95% of its Diagnostics & Research peers (median 8.5%)Significant
Operating margin: 0.31Industry median: 0.09Industry P95: 0.29Peers compared: 30.00
Profit margin is 21.9%, higher than 95% of its Diagnostics & Research peers (median 4%)Significant
Profit margin: 0.22Industry median: 0.04Industry P95: 0.21Peers compared: 30.00
Return on equity is -3677.4%, lower than 95% of its Diagnostics & Research peers (median 1.2%)Significant
Return on equity: -36.77Industry median: 0.01Industry P5: -0.21Peers compared: 30.00
Debt-to-equity is 166.68×, higher than 95% of its Diagnostics & Research peers (median 0.15×)Significant
Debt-to-equity: 166.684Industry median: 0.15Industry P95: 1.36Peers compared: 30.00
Price-to-book is 2361.94×, higher than 95% of its Diagnostics & Research peers (median 2.38×)Significant
Price-to-book: 2,361.938Industry median: 2.38Industry P95: 37.69Peers compared: 30.00
Financial Health
Altman Z-Score 10.48: safe zoneNotable
Altman Z-Score: 10.48
High earnings qualityNotable
Earnings Quality Score: 0.69
High structural barrier to entryNotable
Barrier to Entry: 0.65
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $30.29B, higher than 95% of all stocks globallySignificant
Market cap (USD): 30,288,064,247Global P95: 25,554,966,472.502
Revenue is $4.13B, above the global median of $548.88MNotable
Revenue (USD): 4,133,874,944Global Median: 548,883,780.48
Levered free cash flow is $693.59M, above the global median of $18.73MNotable
Levered free cash flow (USD): 693,589,632Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Chroma ATE Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
ON Semiconductor Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Samsung SDI Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fresenius SE & Co. KGaA
Tier 1ProductionThroughput-Bound ConversionFlowRule
Moore Threads Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Hexagon AB
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Alcon Inc.
Tier 1ProductionThroughput-Bound ConversionRule
Avary Holding (Shenzhen) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Piotech Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Novonesis AS
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Medpace Holdings Inc.
3 interpretationsCash-Flow Ratios ElevatedLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated
NVIDIA Corporation
3 interpretationsCash-Flow Ratios ElevatedLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated
Fiem Industries Ltd.
2 interpretationsLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated